Clinical Trials Logo

Obstetric Labor Complications clinical trials

View clinical trials related to Obstetric Labor Complications.

Filter by:

NCT ID: NCT04773561 Recruiting - Retinal Vascular Clinical Trials

Comparison of Posterior Ocular Changes Between Singleton Pregnancy and Multifetal Pregnancy.

Start date: September 3, 2021
Phase: N/A
Study type: Interventional

It has been known that a pregnant women undergoes significant anatomical and physiological changes that mainly caused by hormonal and hematologic changes during pregnancy. Due to advance in reproductive medicine, the incidence of multifetal pregnancy was increased to 3% of livebirth. Multifetal pregnancies produce much more physiological changes in the body compared to the singleton pregnancies. Physiologic ocular changes during pregnancy are the followings - Melanogenesis of eyelid and facial skin - Cellular alteration of lacrimal and meibomian gland - Increased corneal thickness and corneal curvature - Increased lens thickness - Increased retinal vascular density - Increased choroidal thickness Decreased intraocular pressure -

NCT ID: NCT04489602 Recruiting - Quality of Recovery Clinical Trials

Translation and Validation of the French Version of the ObsQoR-10 Questionnaire

ObsQoR-10F
Start date: February 1, 2021
Phase:
Study type: Observational

Until recently, there was no validated scoring tool to assess recovery after childbirth. Ciechanowicz et al. developed and validated a postpartum recovery score for women with a caesarean section (scheduled or unscheduled): the ObsQoR-11. The psychometric validation of the ObsQoR-11 confirms its reliability, its response to change, its acceptability and its feasibility (average filling time of 2 minutes, and the possibility to print the questionnaire on one page). The use of this score allows the investigators to quantify the quality of the patient's recovery between 0 and 110 (0 being a really poor recovery, and 110 a total recovery), by allocating a score from 0 to 10 for each item. Since then, the initial version of ObsQoR-11 has evolved into a smaller version, ObsQoR-10, for which the pain items have been merged. Similarly, by assigning a score from 0 to 10 for each item, the ObsQoR-10 score allows to quantify the quality of the patient's recovery between 0 and 100 (0 being a very poor recovery, and 100 being full recovery). There are currently no translations of this score into another language, but the investigators can easily assume that they will be done in the near future. French remains the fifth most spoken language in the world. The investigators therefore feel it is necessary to validate the translated version of the ObsQoR-10 score.

NCT ID: NCT04481503 Recruiting - Clinical trials for Cardiovascular Risk Factor

Transthoracic Echocardiography of Ventricular Function of Parturients in Labor

Start date: September 5, 2020
Phase:
Study type: Observational

This echocardiography study will characterize heart structure and function during labor. Imaging of the heart during the stress of labor could increase detection of subclinical cardiovascular disease using advanced imaging techniques. Cardiac serum biomarkers and complication rates will also be measured and compared between patients with and without evidence of cardiovascular disease on echocardiography.

NCT ID: NCT04444206 Recruiting - Preterm Birth Clinical Trials

Prevention of Preterm Birth by Screening of the Consistency Index and Length of the Uterine Cervix in Women With a Single Pregnancy

PreBirthCerv
Start date: April 25, 2020
Phase: N/A
Study type: Interventional

Preterm birth (PTB) is the major cause of perinatal morbidity and mortality. Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as short- and long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB. Other strategies have been adopted for prevention of PTB. The evidence supports the use of vaginal progesterone in singleton pregnancies with short cervix. However, the predictive value of the research has recently been questioned, as the threat rate from preterms in the low-risk population has not decreased over time. Numerous clinical studies have been conducted to improve and identify effective prevention strategies in the threat of preterm birth. Among the parameters studied, in addition to the measurement of the uterine cervix and its complaints during the three trimesters of pregnancy, an evaluation of the cervical consistency index (CCI) was also proposed, i.e. an ultrasound evaluation of cervical softness.

NCT ID: NCT04330742 Recruiting - Pregnancy Related Clinical Trials

The Effect of Fluids on Aortic VTI During C-section

Start date: March 25, 2020
Phase:
Study type: Observational

Pregnancy is associated with a myriad of physiologic changes, including expansion of blood volume, decrease in oncotic pressure, and increased cardiac output. The obstetric population is associated with intrapartum hemorrhage. Accordingly, it is important to have an accurate method to assess fluid status in intrapartum patients. The use of standard volume assessment tools including arterial lines and central venous catheters is limited given the brevity of obstetric procedures and the morbidity of these techniques on the awake patients, and the costs. Non-invasive methods to assess volume status (carotid dopplers, direct measurement of blood loss, bio-impedance devices) are imperfect. Echocardiography is an attractive tool to measure fluid status in experienced operators such as anesthesiologists. IVC diameter and variation of aortic velocity time integral are two measures that can be obtained via echocardiography and been studied in spontaneously breathing patients. The purpose of this study is to determine whether these measurements can be used in the assessment of volume status in the laboring patient.

NCT ID: NCT04303702 Recruiting - Labor Complication Clinical Trials

The Role of Oxytocin in the Second Stage of Labor

ROSSoL
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.

NCT ID: NCT03830879 Recruiting - Clinical trials for Gestational Diabetes

Shenzhen Birth Cohort Study

Start date: March 6, 2018
Phase:
Study type: Observational

The Shenzhen Birth Cohort Study was set up to investigate the effect of early life environmental exposures on short- and long-term health consequences in Shenzhen, China.

NCT ID: NCT03547791 Recruiting - Clinical trials for Twin Pregnancy, Antepartum Condition or Complication

Effects of ACS in Twin With LPB: Study Protocol for a RCT

Start date: May 5, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

This study will be the first study that evaluates the effectiveness of antenatal corticosteroid (ACS) in late preterm twin neonates.

NCT ID: NCT03471858 Recruiting - Pregnancy Related Clinical Trials

Mechanical Dilation of the Cervix in a Scarred Uterus

MEDICS
Start date: February 14, 2019
Phase: N/A
Study type: Interventional

To determine if mechanical labour induction can offer a safer and effective alternative to prostaglandins to women with previous caesarean section attempting trial of labour after caesarean (TOLAC).

NCT ID: NCT03325348 Recruiting - Clinical trials for Severe Pre-Eclampsia, Antepartum

Oral Nifedipine Versus IV Labetalol in Severe Pre Eclampsia

Start date: February 23, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

OBJECTIVE: To determine the efficacy of nifedipine and labetalol in terms of control of BP in pre eclamptic pregnant patients Design: Randomised control trial SETTING: Department Obstetrics & gynaecology, Services Hospital, Services Institute of Medical Sciences. Lahore POPULATION: Pregnant patients with BP 160/110 or symptoms of severe preeclampsia METHODS: Patients are randomised to receive nifedipine (10 mg tablet, orally, up to five doses) and intravenous placebo saline injection or intravenous labetalol injection (in an escalating dose regimen of 20, 40, 80, 80 and 80 mg) and a placebo tablet every 15 minutes until the target blood pressure of ≤140/90mmHg is achieved. Crossover treatment is given if the initial treatment regimen is unsuccessful